Global research trends on anti-PD-1/anti-PD-L1 immunotherapy for triple-negative breast cancer: A scientometric analysis

In recent years, anti-PD-1/anti-PD-L1 has been considered to be a valuable therapeutic target and prognostic indicator for triple-negative breast cancer. We analyzed all publications published in the field from their inception until the present day in order to determine the current research status a...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Jinyao, Chen, Yaokun, Chen, Lingzhi, Ji, Zeqi, Tian, Huiting, Zheng, Daitian, Yang, Qiuping, Liu, Yiyuan, Cai, Jiehui, Zheng, Jiehua, Chen, Yexi, Li, Zhiyang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9875294/
https://www.ncbi.nlm.nih.gov/pubmed/36713507
http://dx.doi.org/10.3389/fonc.2022.1002667

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9875294/
https://www.ncbi.nlm.nih.gov/pubmed/36713507
http://dx.doi.org/10.3389/fonc.2022.1002667

Ejemplares similares